Huddinge, Sweden

Daniel Wiktelius

This inventor holds 3 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Medivir UK Ltd. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Wiktelius. Retrieved from https://idiyas.com/inventor/daniel-wiktelius

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 10.8

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Daniel Wiktelius

Introduction: Daniel Wiktelius is a prominent inventor based in Huddinge, Sweden, known for his significant contributions to the field of biochemistry. With three patents to his name, he has demonstrated a strong commitment to innovation, particularly in developing compounds that advance therapeutic approaches.

Latest Patents: One of Daniel's latest patents focuses on cysteine protease inhibitors, featuring compounds of a specific formula designed to enhance therapeutic efficacy. This patent represents a crucial advancement in the development of new medications targeting various diseases.

Career Highlights: Daniel Wiktelius is currently associated with Medivir UK Ltd, where he continues to apply his inventive spirit toward groundbreaking biopharmaceutical solutions. His work not only contributes to his own research but also fulfills the growing need for innovative approaches to treatment.

Collaborations: Throughout his career, Daniel has collaborated with several esteemed colleagues, including Susana Ayesa and Urszula Grabowska. Together, they cultivate a collaborative spirit that fosters creativity and drives the development of novel solutions in the realm of medicinal chemistry.

Conclusion: Daniel Wiktelius stands out as a dedicated inventor in the biochemistry sector, with a focus on cysteine protease inhibitors. His contributions, alongside his collaborations with talented coworkers, underscore the importance of teamwork and innovation in advancing scientific research and developing effective therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…